Published in Transplant Proc on December 01, 2006
Infectious complications associated with monoclonal antibodies and related small molecules. Clin Microbiol Rev (2009) 0.96
Review on immunosuppression in liver transplantation. World J Hepatol (2015) 0.79
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clin Mol Hepatol (2014) 0.76
Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now? World J Gastroenterol (2015) 0.75
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci U S A (2001) 2.55
Identification of oda6 as a Chlamydomonas dynein mutant by rescue with the wild-type gene. J Cell Biol (1991) 2.42
Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice. Cell (1995) 2.25
Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science (1999) 2.19
Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A (2000) 1.67
Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth (1992) 1.57
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone. Osteoporos Int (2006) 1.56
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene (2009) 1.54
Video-assisted thoracic surgery (VATS) of the lung: analysis of intraoperative and postoperative complications over 15 years and review of the literature. Surg Endosc (2007) 1.47
Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int (1996) 1.45
A compulsive collecting behavior following an A-com aneurysmal rupture. Neurology (2001) 1.44
TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene (2012) 1.43
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42
The hepatic artery in liver transplantation and surgery: vascular anomalies in 701 cases. Clin Transplant (2001) 1.40
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation (1997) 1.39
Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology (1987) 1.39
Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol (1996) 1.36
Effect of donor age and sex on the outcome of liver transplantation. Hepatology (1995) 1.31
Sociodemographic differences in early access to liver transplantation services. Am J Transplant (2009) 1.30
The human tap nuclear RNA export factor contains a novel transportin-dependent nuclear localization signal that lacks nuclear export signal function. J Biol Chem (1999) 1.28
Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis (1997) 1.28
Experimental induction of cerebral aneurysms in monkeys. J Neurosurg (1987) 1.28
Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol (1995) 1.24
Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem (2001) 1.24
Development and experience with an integrated system for transplantation telepathology. Hum Pathol (2001) 1.23
Twitching motility of Ralstonia solanacearum requires a type IV pilus system. Microbiology (2001) 1.23
The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene (2009) 1.23
Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation (1996) 1.22
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest (2000) 1.22
Reversion analysis of dynein intermediate chain function. J Cell Sci (1993) 1.22
Cerebral blood flow patterns at major vessel bifurcations and aneurysms in rats. J Neurosurg (1991) 1.21
Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol (2005) 1.21
Using viral species specificity to define a critical protein/RNA interaction surface. Genes Dev (2001) 1.20
Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg (1996) 1.19
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation (1994) 1.18
Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet (1993) 1.18
Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol (2000) 1.17
Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc (1987) 1.17
Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia (2012) 1.16
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol (1995) 1.15
Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care (1993) 1.15
Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. Clin Infect Dis (1999) 1.15
Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl (2001) 1.14
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res (1996) 1.13
Massive pulmonary thromboembolism during liver transplantation. Anesth Analg (1988) 1.11
Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation (2000) 1.11
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients. Ann Oncol (2011) 1.11
Ion detection with photonic crystal microcavities. Opt Lett (2005) 1.10
Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis (2000) 1.10
Notch signalling in cancer progression and bone metastasis. Br J Cancer (2011) 1.09
Phosphorylation of mitogen-activated protein kinase by one-trial and multi-trial classical conditioning. J Neurosci (1998) 1.06
Motor perseverative behavior on a line cancellation task. Neurology (1999) 1.05
Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer (1995) 1.05
Liver transplantation for metabolic disease of the liver. Gastroenterol Clin North Am (1988) 1.04
Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation (1999) 1.04
Predicting outcomes after liver transplantation. A connectionist approach. Ann Surg (1994) 1.02
Cauda equina syndrome secondary to idiopathic spinal epidural lipomatosis. Spine (Phila Pa 1976) (2001) 1.02
Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Gene Ther (2004) 1.02
A very simple technique to repair Grynfeltt-Lesshaft hernia. Hernia (2009) 1.02
Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant (1997) 1.01
In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol Ther (2001) 0.99
Epidermal growth factor signalling and bone metastasis. Br J Cancer (2009) 0.98
Prospects of clinical xenotransplantation. Transplant Proc (1994) 0.98
Pterygium in an aged Mongolian population: a population-based study in China. Eye (Lond) (2007) 0.98
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation (1989) 0.98
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation (1998) 0.97
P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol (2000) 0.95
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg (1996) 0.95
Clinical evaluation of sodium hyaluronate in the treatment of patients with sopraspinatus tendinosis under echographic guide: experimental study of periarticular injections. Eur J Radiol (2007) 0.95
Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol (1998) 0.94
Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol (1997) 0.94
Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial. Transplantation (2000) 0.94
The voltage-dependent potassium channel subunit Kv2.1 regulates insulin secretion from rodent and human islets independently of its electrical function. Diabetologia (2012) 0.94
Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl (2000) 0.94
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc (1991) 0.94
Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells. Cancer Lett (2000) 0.94
p-Glycoprotein expression as a predictor of breast cancer recurrence. Ann Surg Oncol (1996) 0.93
Indomethacin reduces lung adenoma number in A/J mice. Anticancer Res (2001) 0.93
Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci (1997) 0.93
Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg (1989) 0.92
Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality. J Gastroenterol (1998) 0.92
Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation (1998) 0.92
Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation (1996) 0.92
Fever in liver transplant recipients: changing spectrum of etiologic agents. Clin Infect Dis (1998) 0.92
Prevalence and risk factors for primary open-angle glaucoma in a rural northeast China population: a population-based survey in Bin County, Harbin. Eye (Lond) (2011) 0.92
Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. Transpl Int (1998) 0.91
Software scripts for quality checking of high-throughput nucleic acid sequencers. Biotechniques (2001) 0.91
Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J Immunol (1997) 0.91
Syntaxin-3 regulates newcomer insulin granule exocytosis and compound fusion in pancreatic beta cells. Diabetologia (2012) 0.91
Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in Korea. Epidemiol Infect (2006) 0.91
Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology (1994) 0.91
gly gene cloning and expression and purification of glycinecin A, a bacteriocin produced by Xanthomonas campestris pv. glycines 8ra. Appl Environ Microbiol (2001) 0.90
Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure. Bone Marrow Transplant (2012) 0.90